A vagus nerve schwannoma is a rare, usually benign tumour that develops from the Schwann cells wrapping the vagus nerve. These tumours account for roughly 2–5% of all parapharyngeal space neoplasms and grow slowly, often over years, before producing symptoms. Because they sit deep in the neck between the carotid artery and the internal jugular vein, they present unique diagnostic and surgical challenges.
What a Schwannoma Actually Is
Schwannomas arise from Schwann cells — the cells that produce the myelin sheath insulating peripheral nerves. Unlike neurofibromas, which grow within the nerve fibres themselves, schwannomas grow on the outside of the nerve, typically pushing nerve fascicles aside rather than infiltrating them. This distinction is clinically important: it means surgical removal can sometimes spare the nerve.
Vagal schwannomas are almost always benign (WHO Grade I). Malignant transformation is extremely rare, estimated at less than 1% of cases. They are typically solitary tumours. When multiple schwannomas occur, particularly bilaterally, the clinician should consider neurofibromatosis type 2 (NF2), a genetic condition caused by mutations in the merlin gene on chromosome 22 that predisposes to schwannoma formation throughout the nervous system, including vestibular schwannomas (acoustic neuromas).
Where These Tumours Develop
The vagus nerve runs through the carotid sheath alongside the internal carotid artery and internal jugular vein. Most vagal schwannomas develop in the parapharyngeal space — the deep compartment behind the jaw and below the skull base. They can occur anywhere along the nerve’s cervical course, from the jugular foramen at the skull base down to the lower neck.
Their location within the carotid sheath means vagal schwannomas must be distinguished from other parapharyngeal tumours, particularly carotid body paragangliomas (glomus tumours). A key imaging difference: schwannomas displace the carotid artery anteriorly, while carotid body tumours splay the internal and external carotid arteries apart (the “lyre sign”). This distinction guides surgical planning.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Symptoms and Clinical Presentation
Most vagal schwannomas grow slowly enough that patients may have a painless neck mass for months or years before seeking evaluation. When symptoms do develop, they reflect the nerve’s functions and the tumour’s local effects:
Hoarseness is the most common neurological symptom, occurring when the tumour affects the recurrent laryngeal branch or the main trunk of the vagus nerve. The voice may become breathy, weak, or raspy. Some patients notice voice fatigue with prolonged speaking.
Dysphagia (difficulty swallowing) can develop when the tumour compresses the pharynx or affects the pharyngeal branch. Patients may describe a sensation of food sticking or difficulty initiating a swallow.
Cough or throat clearing may reflect irritation of the superior laryngeal nerve or pharyngeal branches. A chronic cough without pulmonary cause should prompt consideration of vagal pathology.
Horner syndrome (ptosis, miosis, and anhidrosis on the affected side) can occur when a large tumour compresses the cervical sympathetic chain, which runs adjacent to the vagus nerve in the carotid sheath.
Pain is uncommon with schwannomas but may develop with larger tumours or if the tumour undergoes cystic degeneration.
The classic presentation — a slow-growing, painless lateral neck mass with hoarseness — should prompt imaging evaluation.
Diagnostic Workup
MRI with gadolinium contrast is the primary imaging modality. Schwannomas typically appear as well-circumscribed, encapsulated masses that enhance with contrast. They characteristically show a “target sign” on T2-weighted images — central low signal with peripheral high signal — though this pattern is not universal. Larger schwannomas may show heterogeneous signal due to cystic degeneration, haemorrhage, or calcification (the “ancient schwannoma” pattern).
CT with contrast is complementary, particularly for assessing the tumour’s relationship to adjacent bony structures and vascular anatomy. CT angiography or MR angiography can map the carotid and jugular vessels preoperatively.
Fine-needle aspiration (FNA) biopsy can be performed but often yields non-diagnostic results due to the tumour’s low cellularity. When FNA does obtain adequate cells, immunohistochemistry showing strong S-100 protein positivity confirms Schwann cell origin. Preoperative biopsy is not always necessary when imaging characteristics are classic.
Treatment: Surgery, Observation, or Radiation
Observation is appropriate for small, asymptomatic schwannomas, particularly in older patients or those with surgical risk factors. Given the slow growth rate — typically 1–2 mm per year — serial imaging every 6–12 months can safely monitor stable tumours. Many schwannomas remain stable for years without intervention.
Surgical excision remains the definitive treatment when intervention is warranted. The surgical approach depends on tumour size and location. Smaller cervical tumours can be removed through a transcervical approach. Tumours extending to the skull base may require more complex approaches, sometimes involving neurosurgery and otolaryngology teams together.
The central surgical challenge is vagus nerve preservation. Because schwannomas grow eccentrically — pushing nerve fibres around the tumour rather than growing through them — intracapsular dissection can sometimes peel the tumour away from functional nerve fascicles. However, vagal sacrifice is sometimes necessary, particularly with larger tumours where nerve fascicles are severely attenuated. Vagal sacrifice produces ipsilateral vocal cord paralysis requiring speech therapy and potentially medialization procedures. Published series report vagal preservation rates ranging from 30–70% depending on tumour size and surgical technique.
Intraoperative nerve monitoring — placing electrodes on the vocal cords and monitoring electromyographic signals during dissection — has improved nerve preservation rates by providing real-time feedback on nerve integrity during tumour removal.
Stereotactic radiosurgery (Gamma Knife or CyberKnife) is an alternative for patients who are poor surgical candidates or who decline surgery. Radiation doesn’t remove the tumour but can arrest growth in most cases. Local control rates exceed 90% at 5 years. The main disadvantage is that the tumour remains in place, and radiation itself carries a small risk of malignant transformation (estimated at less than 1% over 10–15 years). Fractionated stereotactic radiotherapy may reduce late radiation effects compared with single-fraction radiosurgery.
Prognosis and Follow-Up
The prognosis for vagal schwannomas is generally excellent. Complete surgical resection is curative, with recurrence rates under 5% for completely excised tumours. Even with observation or radiation, the benign natural history means most patients do well long-term.
The main morbidity is from treatment rather than the tumour itself — specifically, vocal cord paralysis from vagal injury during surgery. Patients with post-surgical vocal cord paralysis typically undergo speech therapy and may benefit from vocal cord injection medialization or thyroplasty to restore voice quality.
Patients with NF2-associated schwannomas require lifelong surveillance for new tumour development at other nerve sites, including bilateral vestibular schwannomas, meningiomas, and spinal tumours.
For anyone with a persistent neck mass, progressive hoarseness, or unexplained swallowing difficulty, evaluation by an otolaryngologist or head-and-neck surgeon is the appropriate first step. While vagal schwannomas are rare, early diagnosis allows for the widest range of management options.
The vagus nerve is the body’s longest cranial nerve, influencing everything from voice and swallowing to heart rate and digestion. To understand the full scope of what it does — and what can go wrong — get the Vagus Nerve & Me eBook.
